Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis
Table 3
Comparison of the surviving and nonsurviving patients with HBV-DeCi.
Nonsurviving patients ()
Surviving patients ()
Gender (female/male)
7/31
11/52
0.884
Age (years)
0.453
Total protein (g/L)
59.6 (54.4-63.7)
59.9 (56.0-66.4)
0.497
Albumin (g/L)
28.9 (24.7-31.2)
30.1 (26.4-33.9)
0.044
ALT (U/L)
32.5 (17.0-60.0)
32.0 (20.0-48.0)
0.715
AST (U/L)
52.5 (34.0-86.0)
48.0 (29.5-72.8)
0.348
Serum creatinine (μmol/L)
74.5 (66.0-100.0)
73.0 (58.3-83.0)
0.147
Total bilirubin (μmol/L)
97.5 (50.0-203.0)
36.0 (21.0-93.0)
0.001
INR
0.036
MPV (fl)
17.6 (15.0-19.7)
15.1 (13.0-17.7)
0.008
Lymphocyte count (×109/L)
0.75 (0.50-1.10)
1.30 (0.73-1.88)
<0.001
MPVLR
22.1 (15.8-37.8)
11.5 (8.8-18.6)
<0.001
PLTs (×109/L)
47.0 (31.0-80.0)
83.0 (54.3-151.0)
0.002
MELD score
17.3 (12.2-20.5)
10.7 (6.9-16.5)
<0.001
CP score
11.0 (9.0-11.0)
9.0 (8.0-11.0)
0.014
Data are expressed as ,, or median (interquartile range). Abbreviations: ALT: alanine aminotransferase; AST: aspartate aminotransferase; INR: international normalized ratio; MPV: mean platelet volume; MPVLR: mean platelet volume/lymphocyte ratio; PLTs: platelet counts; MELD score: model for end-stage liver disease score; CP score: Child-Pugh score; HBV-DC: HBV-related-decompensated cirrhosis.
